{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:40:02Z","timestamp":1749591602417,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10549-016-3985-7","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T12:52:27Z","timestamp":1474635147000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment with aromatase inhibitors and markers of cardiovascular disease"],"prefix":"10.1007","volume":"160","author":[{"given":"Eva","family":"Blondeaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Musio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Bruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Gazzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Poggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Levaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"D\u2019Alonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cecilia","family":"Perfumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Bighin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Giraudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Palombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Del Mastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"3985_CR1","unstructured":"European Heart Network (2012) European cardiovascular disease statistics. www.escardio.org"},{"key":"3985_CR2","first-page":"1","volume":"64","author":"J Xu","year":"2016","unstructured":"Xu J, Murphy SL, Kochanek KD, Bastian BA (2016) Deaths: final data for 2013. Natl Vital Stat Rep 64:1\u2013119","journal-title":"Natl Vital Stat Rep"},{"key":"3985_CR3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.95.1.252","volume":"95","author":"E Barrett-Connor","year":"1997","unstructured":"Barrett-Connor E (1997) Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel keys lecture. Circulation 95:252\u2013264","journal-title":"Circulation"},{"key":"3985_CR4","first-page":"9","volume":"6","author":"K Saltiki","year":"2007","unstructured":"Saltiki K, Alevizaki M (2007) Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Horm Athens Greece 6:9\u201324","journal-title":"Horm Athens Greece"},{"key":"3985_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1067\/mva.2001.115275","volume":"34","author":"FA Lederle","year":"2001","unstructured":"Lederle FA, Johnson GR, Wilson SE, Aneurysm detection and management veterans affairs cooperative study (2001) Abdominal aortic aneurysm in women. J Vasc Surg 34:122\u2013126. doi: 10.1067\/mva.2001.115275","journal-title":"J Vasc Surg"},{"key":"3985_CR6","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801\u20131811. doi: 10.1056\/NEJM199906103402306","journal-title":"N Engl J Med"},{"key":"3985_CR7","doi-asserted-by":"crossref","first-page":"3F","DOI":"10.1016\/S0002-9149(02)02418-9","volume":"90","author":"ME Mendelsohn","year":"2002","unstructured":"Mendelsohn ME (2002) Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90:3F\u20136F","journal-title":"Am J Cardiol"},{"key":"3985_CR8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3565(24)35134-1","volume":"291","author":"J Case","year":"1999","unstructured":"Case J, Davison CA (1999) Estrogen alters relative contributions of nitric oxide and cyclooxygenase products to endothelium-dependent vasodilation. J Pharmacol Exp Ther 291:524\u2013530","journal-title":"J Pharmacol Exp Ther"},{"key":"3985_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0034-1384624","volume":"32","author":"RL Prentice","year":"2014","unstructured":"Prentice RL (2014) Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med 32:419\u2013425. doi: 10.1055\/s-0034-1384624","journal-title":"Semin Reprod Med"},{"issue":"Suppl 6","key":"3985_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/annonc\/mdt284","volume":"24","author":"E Senkus","year":"2013","unstructured":"Senkus E, Kyriakides S, Penault-Llorca F et al (2013) Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):7\u201323. doi: 10.1093\/annonc\/mdt284","journal-title":"Ann Oncol"},{"key":"3985_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","volume":"26","author":"AS Coates","year":"2015","unstructured":"Coates AS, Winer EP, Goldhirsch A et al (2015) Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 26:1533\u20131546. doi: 10.1093\/annonc\/mdv221","journal-title":"Ann Oncol"},{"key":"3985_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","volume":"32","author":"HJ Burstein","year":"2014","unstructured":"Burstein HJ, Temin S, Anderson H et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32:2255\u20132269. doi: 10.1200\/JCO.2013.54.2258","journal-title":"J Clin Oncol"},{"key":"3985_CR13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.20.3.751","volume":"20","author":"J Geisler","year":"2002","unstructured":"Geisler J, Haynes B, Anker G et al (2002) Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20:751\u2013757","journal-title":"J Clin Oncol"},{"key":"3985_CR14","first-page":"2089","volume":"4","author":"J Geisler","year":"1998","unstructured":"Geisler J, King N, Anker G et al (1998) In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clin Cancer Res 4:2089\u20132093","journal-title":"Clin Cancer Res"},{"key":"3985_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2015.03.005","author":"Y-P Lim","year":"2015","unstructured":"Lim Y-P, Lin C-L, Lin Y-N et al (2015) Tamoxifen treatment and the reduced risk of hyperlipidemia in Asian patients with breast cancer: a population-based cohort study. Clin Breast Cancer. doi: 10.1016\/j.clbc.2015.03.005","journal-title":"Clin Breast Cancer"},{"key":"3985_CR16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1049-3867(01)00075-5","volume":"11","author":"DM Herrington","year":"2001","unstructured":"Herrington DM, Klein KP (2001) Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function. Womens Health Issues 11:95\u2013102","journal-title":"Womens Health Issues"},{"key":"3985_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","volume":"365","author":"A Howell","year":"2005","unstructured":"Howell A, Cuzick J, Baum M et al (2005) Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5\u00a0years\u2019 adjuvant treatment for breast cancer. Lancet Lond Engl 365:60\u201362. doi: 10.1016\/S0140-6736(04)17666-6","journal-title":"Lancet Lond Engl"},{"key":"3985_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(10)62312-4","volume":"377","author":"CJH Velde van de","year":"2011","unstructured":"van de Velde CJH, Rea D, Seynaeve C et al (2011) Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial. Lancet Lond Engl 377:321\u2013331. doi: 10.1016\/S0140-6736(10)62312-4","journal-title":"Lancet Lond Engl"},{"key":"3985_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"R Jakesz","year":"2005","unstructured":"Jakesz R, Jonat W, Gnant M et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2\u00a0years\u2019 adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet Lond Engl 366:455\u2013462. doi: 10.1016\/S0140-6736(05)67059-6","journal-title":"Lancet Lond Engl"},{"key":"3985_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1200\/JCO.2006.08.8617","volume":"25","author":"AS Coates","year":"2007","unstructured":"Coates AS, Keshaviah A, Th\u00fcrlimann B et al (2007) Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1\u201398. J Clin Oncol 25:486\u2013492. doi: 10.1200\/JCO.2006.08.8617","journal-title":"J Clin Oncol"},{"key":"3985_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ctrv.2006.07.012","volume":"32","author":"M Venturini","year":"2006","unstructured":"Venturini M, Del Mastro L (2006) Safety of adjuvant aromatase inhibitor therapy. Cancer Treat Rev 32:548\u2013556. doi: 10.1016\/j.ctrv.2006.07.012","journal-title":"Cancer Treat Rev"},{"key":"3985_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61074-1","author":"Early breast cancer trialists\u2019 collaborative group (EBCTCG)","year":"2015","unstructured":"Early breast cancer trialists\u2019 collaborative group (EBCTCG) (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet Lond Engl. doi: 10.1016\/S0140-6736(15)61074-1","journal-title":"Lancet Lond Engl"},{"key":"3985_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2010.09.047","volume":"57","author":"A Steinvil","year":"2011","unstructured":"Steinvil A, Sadeh B, Arbel Y et al (2011) Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol 57:779\u2013783. doi: 10.1016\/j.jacc.2010.09.047","journal-title":"J Am Coll Cardiol"},{"key":"3985_CR24","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(08)60691-1","volume":"371","author":"CA Pickett","year":"2008","unstructured":"Pickett CA, Jackson JL, Hemann BA, Atwood JE (2008) Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis. Lancet Lond Engl 371:1587\u20131594. doi: 10.1016\/S0140-6736(08)60691-1","journal-title":"Lancet Lond Engl"},{"key":"3985_CR25","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/oxfordjournals.aje.a009302","volume":"146","author":"LE Chambless","year":"1997","unstructured":"Chambless LE, Heiss G, Folsom AR et al (1997) Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the atherosclerosis risk in communities (ARIC) study, 1987\u20131993. Am J Epidemiol 146:483\u2013494","journal-title":"Am J Epidemiol"},{"key":"3985_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejvs.2013.12.011","volume":"47","author":"R Durieux","year":"2014","unstructured":"Durieux R, Van Damme H, Labropoulos N et al (2014) High prevalence of abdominal aortic aneurysm in patients with three-vessel coronary artery disease. Eur J Vasc Endovasc Surg 47:273\u2013278. doi: 10.1016\/j.ejvs.2013.12.011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3985_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2015.04.001","author":"JF Polak","year":"2015","unstructured":"Polak JF, Szklo M, O\u2019Leary DH (2015) Associations of coronary heart disease with common carotid artery near and far wall intima-media thickness: the multi-ethnic study of atherosclerosis. J Am Soc Echocardiogr. doi: 10.1016\/j.echo.2015.04.001","journal-title":"J Am Soc Echocardiogr"},{"key":"3985_CR28","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1067\/mva.1991.26737","volume":"13","author":"KW Johnston","year":"1991","unstructured":"Johnston KW, Rutherford RB, Tilson MD et al (1991) Suggested standards for reporting on arterial aneurysms. subcommittee on reporting standards for arterial aneurysms, ad hoc committee on reporting standards, society for vascular surgery and North American chapter, international society for cardiovascular surgery. J Vasc Surg 13:452\u2013458","journal-title":"J Vasc Surg"},{"key":"3985_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1161\/STROKEAHA.110.581058","volume":"41","author":"M Weerd de","year":"2010","unstructured":"de Weerd M, Greving JP, Hedblad B et al (2010) Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis. Stroke J Cereb Circ 41:1294\u20131297. doi: 10.1161\/STROKEAHA.110.581058","journal-title":"Stroke J Cereb Circ"},{"key":"3985_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jvs.2007.06.024","volume":"46","author":"BG Derubertis","year":"2007","unstructured":"Derubertis BG, Trocciola SM, Ryer EJ et al (2007) Abdominal aortic aneurysm in women: prevalence, risk factors, and implications for screening. J Vasc Surg 46:630\u2013635. doi: 10.1016\/j.jvs.2007.06.024","journal-title":"J Vasc Surg"},{"key":"3985_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.0429","author":"R Haque","year":"2016","unstructured":"Haque R, Shi J, Schottinger JE et al (2016) Cardiovascular disease after aromatase inhibitor use. JAMA Oncol. doi: 10.1001\/jamaoncol.2016.0429","journal-title":"JAMA Oncol"},{"key":"3985_CR32","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/jnci\/dji250","volume":"97","author":"PE Goss","year":"2005","unstructured":"Goss PE, Ingle JN, Martino S et al (2005) Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97:1262\u20131271. doi: 10.1093\/jnci\/dji250","journal-title":"J Natl Cancer Inst"},{"key":"3985_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10549-013-2457-6","volume":"138","author":"J Rosell","year":"2013","unstructured":"Rosell J, Nordenskj\u00f6ld B, Bengtsson N-O et al (2013) Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up. Breast Cancer Res Treat 138:467\u2013473. doi: 10.1007\/s10549-013-2457-6","journal-title":"Breast Cancer Res Treat"},{"key":"3985_CR34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1046\/j.1525-1497.2003.20724.x","volume":"18","author":"RS Braithwaite","year":"2003","unstructured":"Braithwaite RS, Chlebowski RT, Lau J et al (2003) Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med 18:937\u2013947","journal-title":"J Gen Intern Med"},{"key":"3985_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2016.02.011","author":"L Gallicchio","year":"2016","unstructured":"Gallicchio L, Calhoun C, Helzlsouer K (2016) Effect of aromatase inhibitor therapy on the cardiovascular health of black and white breast cancer patients. Clin Breast Cancer. doi: 10.1016\/j.clbc.2016.02.011","journal-title":"Clin Breast Cancer"},{"key":"3985_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-016-3761-8","volume":"156","author":"J-AW Chapman","year":"2016","unstructured":"Chapman J-AW, Shepherd LE, Ingle JN et al (2016) Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27. Breast Cancer Res Treat 156:343\u2013349. doi: 10.1007\/s10549-016-3761-8","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-016-3985-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-016-3985-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T21:00:56Z","timestamp":1749589256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-016-3985-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3985"],"URL":"https:\/\/doi.org\/10.1007\/s10549-016-3985-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2016,9,23]]}}}